Invesco Pharmaceuticals ETF Rating $93.06 +0.42 (+0.45%) As of 12:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.64Holdings in PJP have an aggregate rating of Moderate Buy based on 400 analyst ratings issued in the past year covering 25 companies (88.0% of the portfolio).PJP Aggregate Price Target$93.06High Prediction$93.06Average Prediction$93.06Low Prediction$93.06Holdings in PJP have an aggregate price target of $93.06 and a range of $93.06 to $93.06 covering 25 companies (88.0% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.22%ABBVAbbVie$227.21-0.1%4.6077 of 5 stars2.71$231.90 2.1%28Trending NewsAnalyst ForecastOptions VolumeAnalyst Revision5.03%ABTAbbott Laboratories$128.54-3.1%4.976 of 5 stars2.91$146.17 13.7%22Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap Down4.98%LLYEli Lilly and Company$827.75+1.9%4.9964 of 5 stars2.68$948.06 14.5%25Trending NewsAnalyst UpgradeAnalyst Revision4.95%JNJJohnson & Johnson$190.830.0%4.7188 of 5 stars2.74$200.44 5.0%23Trending NewsEarnings ReportDividend AnnouncementAnalyst Forecast4.89%GILDGilead Sciences$118.24-0.2%4.8882 of 5 stars2.86$118.08 -0.1%29Positive News4.78%PFEPfizer$24.42-0.4%4.9768 of 5 stars2.37$28.35 16.1%19Trending NewsDividend AnnouncementAnalyst Revision4.76%AMGNAmgen$297.25+1.2%4.5309 of 5 stars2.35$309.42 4.1%20Positive NewsAnalyst Revision4.63%MRKMerck & Co., Inc.$83.76-1.1%4.9985 of 5 stars2.29$105.00 25.4%21Trending NewsAnalyst ForecastAnalyst Revision3.82%UTHRUnited Therapeutics$435.82+0.5%4.3495 of 5 stars2.67$457.21 4.9%153.77%TVTXTravere Therapeutics$26.37+0.9%2.1123 of 5 stars2.73$35.21 33.5%153.25%CORTCorcept Therapeutics$77.52+7.5%4.8998 of 5 stars2.57$135.25 74.5%72.86%SUPNSupernus Pharmaceuticals$49.53+0.6%4.1554 of 5 stars3.00$64.00 29.2%52.85%LGNDLigand Pharmaceuticals$184.37+1.9%4.0299 of 5 stars2.71$176.50 -4.3%72.83%AVDLAvadel Pharmaceuticals$14.59+1.5%2.7082 of 5 stars2.70$20.86 43.0%102.79%AMRXAMNEAL PHARMACEUTICALS$9.74+0.2%3.2454 of 5 stars2.80$12.00 23.3%52.79%ANIPANI Pharmaceuticals$90.10+1.5%3.9408 of 5 stars2.90$99.14 10.0%10News Coverage2.79%JAZZJazz Pharmaceuticals$133.34-0.4%4.591 of 5 stars2.76$178.93 34.2%17Analyst Revision2.75%OCULOcular Therapeutix$11.63+3.6%3.946 of 5 stars2.75$22.63 94.5%122.71%BIIBBiogen$143.12-1.5%4.6658 of 5 stars2.32$180.69 26.3%31Analyst ForecastAnalyst Revision2.70%PCRXPacira BioSciences$23.13+1.8%3.7845 of 5 stars2.43$33.40 44.4%7Positive News2.65%REGNRegeneron Pharmaceuticals$578.54+1.0%4.764 of 5 stars2.79$817.88 41.4%29Trending NewsAnalyst ForecastAnalyst Revision2.57%PBHPrestige Consumer Healthcare$61.76-0.2%4.6737 of 5 stars2.43$94.80 53.5%7Positive News2.56%INVAInnoviva$16.99+1.9%4.8257 of 5 stars2.71$37.60 121.3%72.53%TARSTarsus Pharmaceuticals$72.55+3.9%0.6834 of 5 stars2.50$66.67 -8.1%82.52%BMYBristol Myers Squibb$43.76-0.1%4.9884 of 5 stars2.33$57.14 30.6%21Analyst ForecastAnalyst Revision This page (NYSEARCA:PJP) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
